Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Rehan M. Faridi"'
Autor:
Mary Lynn Savoie, Jan Storek, Megan Kinzel, Mona Shafey, Rehan M. Faridi, Faisal Khan, Rutvij A. Khanolkar, Kareem Jamani
Publikováno v:
Cytotherapy. 24:413-420
Background aims The internal tandem duplication of FLT3 (FLT3ITD) and NPM1 mutations (NPM1mut) are well-established prognostic factors in cytogenetically intermediate-risk acute myeloid leukemia (AML) when treated with chemotherapy alone. However, th
Autor:
Gaurav Tripathi, Rutvij A. Khanolkar, Rehan M. Faridi, Amit Kalra, Poonam Dharmani-Khan, Meer-Taher Shabani-Rad, Noureddine Berka, Andrew Daly, Jan Storek, Faisal M. Khan
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 24; Pages: 15888
The persistence of graft-versus-host disease (GVHD) as the principal complication of allogeneic hematopoietic cell transplantation (HCT) demonstrates that HLA matching alone is insufficient to prevent alloreactivity. We performed molecular and functi
Autor:
Yan Liu, Rehan M. Faridi, Dylan R. Pillai, Daniel Castañeda-Mogollón, Claire Kamaliddin, Abu Naser Mohon, Lisa Oberding, Faisal Khan
Publikováno v:
Journal of Clinical Virology
An unbiased metagenomics approach to virus identification can be essential in the initial phase of a pandemic. Better molecular surveillance strategies are needed for the detection of SARS-CoV-2 variants of concern and potential co-pathogens triggeri
Autor:
Arabesque Parker, Jan Storek, Poonam Dharmani-Khan, Meer Taher Shabani-Rad, Minal Borkar Tripathi, Wendy I. Sligl, Faisal Khan, Jan Willem Cohen Tervaert, Rehan M. Faridi, Amit Kalra, Mohammed Osman
Publikováno v:
Blood Advances
Key Points NK-cell levels and activity are impaired in severe COVID-19 patients. Reduced NK-cell activity, elevated sCD25, and hyperferritinemia are indicative of immune dysregulation in severe COVID-19.
The global pandemic of severe acute respi
The global pandemic of severe acute respi
Autor:
Michael Paul Kolinsky, D.Y.C. Heng, Minal Borkar, Geoffrey Gotto, John D. Lewis, Joseph D. Ruether, S.E. El Hallani, Tarek A. Bismar, S. Cook, Daniel Khalaf, Adrian Fairey, Richard Gagnon, Nimira S. Alimohamed, Rehan M. Faridi, Richard M. Lee-Ying, Steven Yip, Catalina Vasquez, D. Samuel
Publikováno v:
Annals of Oncology. 32:S647
Publikováno v:
Microbiology and immunologyREFERENCES. 64(3)
Susceptibility to abacavir hypersensitivity (ABH) in HIV-1-positive patients is strongly linked to the carriage of HLA-B*57:01 and the potential mechanism includes drug-specific activation of cytokine producing CD8 T cells exclusively in individuals
Autor:
Meer-Taher Shabani-Rad, Etienne Mahe, Gaurav Tripathi, Rehan M. Faridi, Gary D. Sinclair, Jan Storek, Faisal Khan
Publikováno v:
Human Immunology. 80:136
Autor:
Ahmed A. Mostafa, Noureddine Berka, Meer-Taher Shabani-Rad, Rehan M. Faridi, Douglas A. Stewart, Jan Storek, Ariz Akhter, Faisal Khan, Yacine Berka
Publikováno v:
Human Immunology. 80:50
Autor:
Serdar Yilmaz, Brittin Adams, Alison J. Gareau, Rehan M. Faridi, Noureddine Berka, Ariz Akhter, Faisal Khan
Publikováno v:
Human Immunology. 80:101
Autor:
Andrew Daly, Stuti Patel, Meer-Taher Shabani-Rad, Rehan M. Faridi, Amit Kalra, Jan Storek, Faisal Masood Khan, Adnan Mansoor, Victor Lewis, Poonam Dharmani-Khan
Publikováno v:
Web of Science
Introduction Chronic graft versus host disease is the major cause of poor outcomes after allogeneic hematopoietic cell transplantation (HCT). Clinically significant moderate-severe chronic GvHD (cGvHD) rarely shows a sustained complete response to im